Incorporating High-Risk Individuals Beyond Smoking History Into Lung Cancer Screening in Hong Kong: A Cost-Effectiveness Study
LCS with LDCT can be considered cost-effective in HK for high-risk individuals on the basis of smoking history and factors other than smoking history, contributing to the health benefits of the population. Our findings support a population-based LCS for all high-risk individuals identified through criteria beyond smoking history.
Authors
- Pan‐Chyr Yang (ORCID: https://orcid.org/0000-0001-6330-6048)
- Maarten Jacobus Postma (ORCID: https://orcid.org/0000-0002-6306-3653)
- Molly Li (ORCID: https://orcid.org/0000-0002-6460-5514)
- Herbert H. Loong (ORCID: https://orcid.org/0000-0002-6607-1106)
- Lisa A. de Jong (ORCID: https://orcid.org/0000-0001-8814-0670)
- Carlos King Ho Wong (ORCID: https://orcid.org/0000-0002-6895-6071)
- Matthew Shing Hin Chung (ORCID: https://orcid.org/0000-0002-1669-4479)
- Szu‐Chun Yang (ORCID: https://orcid.org/0000-0003-4120-0394)
- Harry J.M. Groen (ORCID: https://orcid.org/0000-0002-2978-5265)
- Chao‐Hua Chiu (ORCID: https://orcid.org/0000-0001-8401-2356)
- Xuanqi Pan (ORCID: https://orcid.org/0000-0001-5237-3544)
Institutions
- Department of Health (CN)
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Chinese University of Hong Kong (HK)
- Universitas Airlangga (ID)
- Taipei Medical University Hospital (TW)
- London School of Hygiene & Tropical Medicine (GB)
- National Taiwan University Hospital (TW)
- National Cheng Kung University Hospital (TW)
- University of Hong Kong (HK)
- Padjadjaran University (ID)
Publication Details
- Journal
- JTO Clinical and Research Reports
- Published
- 2025-06-13
- DOI
- https://doi.org/10.1016/j.jtocrr.2025.100860
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00